Vascular Endothelial Growth Factor Inhibitors Market Poised for 4% CAGR, Expanding Across APAC, Europe and USA
VEGF inhibitors market to grow from US$22.7B in 2022 to US$33.5B by 2032 at 4% CAGR, driven by biologics and advanced ocular & oncology therapies. GERMANY, November 11, 2025 /EINPresswire.com/ -- The global Vascular Endothelial Growth Factor …